The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

May 29, 2009

Greetings from Manila Philippines!

Hi Doc Barbara,

Last Feb my CD4 count was 99 and just last April it was 163. I stop interferon treatment last Feb (after 6 months) but my doctor insist to finish the 48 weeks treatment. Should I continue interferon?

I am a bit treatment naive and paranoid about getting OI's.

Thanks a lot


Response from Dr. McGovern

I am unclear if you are currently on your third month of interferon treatment or not. If so, I would want to know your HCV RNA level on treatment to determine if you should continue interferon and ribavirin therapy. If suppressed at 12 weeks, I would continue; if not, I would stop.

An important issue is to follow your CD4 percentage which can be more informative. If your CD4% is 15% or more, you will probably do okay.

If your CD4 percentage if low (eg, 10% or less), then I would certainly think about starting prophylaxis. If you are developing thrush or other problems, then you would want to start HIV treatment even earlier - regardless of CD4 count.

I would also

medication in case of low viremia
cd4 after finish interferon

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint